196 related articles for article (PubMed ID: 36949071)
1. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
3. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
[TBL] [Abstract][Full Text] [Related]
4. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.
Zhang Q; Chen Z; Tang Q; Wang Z; Lu J; You Y; Wang H
Cell Death Dis; 2022 Aug; 13(8):712. PubMed ID: 35974001
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.
Sun T; Xu YJ; Jiang SY; Xu Z; Cao BY; Sethi G; Zeng YY; Kong Y; Mao XL
Acta Pharmacol Sin; 2021 Aug; 42(8):1338-1346. PubMed ID: 33184448
[TBL] [Abstract][Full Text] [Related]
6. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
[TBL] [Abstract][Full Text] [Related]
7. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S
Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074
[TBL] [Abstract][Full Text] [Related]
9. USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
Ouchida AT; Kacal M; Zheng A; Ambroise G; Zhang B; Norberg E; Vakifahmetoglu-Norberg H
Biochem Biophys Res Commun; 2018 Aug; 502(4):429-434. PubMed ID: 29803676
[TBL] [Abstract][Full Text] [Related]
10. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract][Full Text] [Related]
13. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
[No Abstract] [Full Text] [Related]
14. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
15. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.
Cao YF; Xie L; Tong BB; Chu MY; Shi WQ; Li X; He JZ; Wang SH; Wu ZY; Deng DX; Zheng YQ; Li ZM; Xu XE; Liao LD; Cheng YW; Li LY; Xu LY; Li EM
Cell Death Differ; 2023 Feb; 30(2):527-543. PubMed ID: 36526897
[TBL] [Abstract][Full Text] [Related]
16. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation.
Xu YJ; Zeng K; Ren Y; Mao CY; Ye YH; Zhu XT; Sun ZY; Cao BY; Zhang ZB; Xu GQ; Huang ZQ; Mao XL
Acta Pharmacol Sin; 2023 Sep; 44(9):1920-1931. PubMed ID: 37055530
[TBL] [Abstract][Full Text] [Related]
19. Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.
Bogoch Y; Friedlander-Malik G; Lupu L; Bondar E; Zohar N; Langier S; Ram Z; Nachmany I; Klausner JM; Pencovich N
Tumour Biol; 2017 Apr; 39(4):1010428317698357. PubMed ID: 28443460
[TBL] [Abstract][Full Text] [Related]
20. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
Wang H; Li L; Yin L
Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
